30 mCi Radioiodine Treatment of Thyroid Carcinoma Patients in the post ESTIMABL Era

被引：0
|
作者：
Rusu, D. [1 ]
Fleury, V. [1 ]
Palpacuer, C. [2 ]
Le Thiec, M. [1 ]
Colombie, M. [1 ]
Kraeber-Bodere, F. [1 ,3 ,4 ]
Rousseau, C. [1 ,4 ]
机构：
[1] ICO Canc Fighting Ctr, Nucl Med, St Herblain, France
[2] ICO Canc Fighting Ctr, Stat Unit, St Herblain, France
[3] Univ Hosp, Nucl Med, Nantes, France
[4] CNRS, INSERM, CRCNA, U892,UMR 6299, Nantes, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-568
引用
收藏
页码：S324 / S324
页数：1
相关论文
共 50 条
  • [41] Comparison of 30 mCi and 50 mCi I-131 doses for ablation of thyroid remnant in papillary thyroid cancer patients
    Cai, Xiao Yue
    Vijayaratnam, Niranjan
    McEwan, Alexander J. B.
    Reif, Rebecca
    Morrish, Donald W.
    ENDOCRINE RESEARCH, 2018, 43 (01) : 11 - 14
  • [42] Thyroid Ablation with 1.1GBq (30 mCi) Iodine-131 in Patients with Papillary Thyroid Carcinoma at Intermediate Risk for Recurrence
    Rosario, Pedro Weslley
    Calsolari, Maria Regina
    THYROID, 2014, 24 (05) : 826 - 831
  • [43] Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study
    Hesselink, Esther N. Klein
    Brouwers, Adrienne H.
    de Jong, Johan R.
    van der Horst-Schrivers, Anouk N. A.
    Coppes, Rob P.
    Lefrandt, Joop D.
    Jager, Piet L.
    Vissink, Arjan
    Links, Thera P.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (11) : 1685 - 1691
  • [44] Lymphocyte function following radioiodine therapy in patients with thyroid carcinoma
    Barsegian, V.
    Mueller, S. P.
    Horn, P. A.
    Bockisch, A.
    Lindemann, M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (05): : 195 - 203
  • [45] Radioiodine Therapy Induced Cytotoxicity in Patients with Differentiated Thyroid Carcinoma
    Hooman, A.
    Mogharrabi, M.
    Solooki, M.
    Mosaffa, N.
    Tabeie, F.
    Shafiee, B.
    Asli, Neshandar, I
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2008, 6 (03) : 135 - 139
  • [46] Radioiodine scan feature [multifocal versus unifocal pattern] as the determinant for radioiodine ablative treatment dose in patients of Differentiated Thyroid Carcinoma
    Singh, P.
    Basu, S.
    Asopa, R.
    Rajan, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S731 - S731
  • [47] Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer
    Buscombe, John
    SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (04) : 475 - 480
  • [48] Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective
    Higuchi, Tetsuya
    Achmad, Arifudin
    Duong Duc Binh
    Bhattarai, Anu
    Tsushima, Yoshito
    ENDOCRINE JOURNAL, 2018, 65 (03) : 345 - 357
  • [49] Ablative radioiodine treatment in children with differentiated thyroid carcinoma - own experience
    Czepczynski, R.
    Rabska-Pietrzak, B.
    Ziemnicka, K.
    Czarnywojtek, A.
    Baczyk, M.
    Niedziela, M.
    Sowinski, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S196 - S196
  • [50] MYELODYSPLASTIC SYNDROME FOLLOWING TREATMENT OF A DIFFERENTIATED THYROID-CARCINOMA WITH RADIOIODINE
    PASCUAL, LG
    SIMO, R
    MESA, J
    GALOFRE, P
    REVISTA CLINICA ESPANOLA, 1992, 191 (03): : 169 - 170
12345